Blog

Home » Blog

VIDEO: Rocco Rossi visits PCCN Toronto

Videos, Awareness Nights, News / By / / 1 minute of reading

March 2013 Scotiabank Awateness Night Rocco Rossi visits PCCN Toronto Prostate Cancer Canada ,President & Chief Executive Officer (CEO) Managing Director of PCCN  Rocco Rossi is a Canadian businessman, executive and former political candidate. After graduating from McGill and Princeton University, Rocco’s career included positions with Advanced Material Resources, The Boston Consulting Group, Torstar, Labatt/Interbrew and MGI Software. Rocco’s vast board experience is through his work with the United Way of Greater Toronto, AMR, the Ivey Foundation, the Internet Advertising Bureau of Canada, Toronto’s 2008 Olympic Bid and the Empire Club of Canada. He is also a supporter of Rotary […]

VIDEO: Rocco Rossi visits PCCN Toronto Read More »

First genetic factor in prostate cancer prognosis identified

Genetics / By / / 1 minute of reading

Patients with prostate cancer and hereditary mutations in the BRCA2 gene have a worse prognosis and lower survival rates than do the rest of the patients with the disease. This is the main conclusion to come out of a study published this week in the Journal of Clinical Oncology, in which David Olmos, Head of the Prostate Cancer and Genitourinary Tumours Clinical Research Unit at the Spanish National Cancer Research Centre (CNIO), has taken part in, along with Elena Castro, a member of the Unit, and British researchers at The Institute of Cancer Research and The Royal Marsden NHS Foundation

First genetic factor in prostate cancer prognosis identified Read More »

Focal Therapy for Prostate Cancer Advances

Brachytherapy, Focal Therapy / By / / 1 minute of reading

Laser ablation, cryotherapy, and hemiablative brachytherapy are among the novel approaches that show promise for the focal treatment of localized prostate cancer (PCa), according to studies presented at the 28th annual congress of the European Association of Urology. Most of these treatments are performed under magnetic resonance imaging (MRI) guidance. Read the article.

Focal Therapy for Prostate Cancer Advances Read More »

Awareness: The “PCCN-Toronto” and “Side by Side” Prostate Cancer Support Groups Newsletter March 2013

Newsletters / By / / 1 minute of reading

To read the full newsletter please click here: Awareness: The “PCCN-Toronto” and “Side by Side” Prostate Cancer Support Groups Newsletter March 2013 (pdf) In this issue: Dr. Laurence Klotz / New member of the board / Bill Sceviour steps down / Dr. Keith Jarvi – March 27th / North York Harvest Food Bank / Thank you to Scotiabank / 2013 Conference Postponed / Our Voice magazine / Volunteers are needed / Meet John Roth / PCC’s new President & CEO / PCC’s New Advisory Council / Walk/Run Instructions / PCCN-Toronto Word Search / On-going Projects for 2013 / PCCN-Toronto Board

Awareness: The “PCCN-Toronto” and “Side by Side” Prostate Cancer Support Groups Newsletter March 2013 Read More »

Focal Therapy Offers Middle Ground for Some Prostate Cancer Patients

Focal Therapy / By / / 1 minute of reading

Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option. Focal laser ablation uses precisely targeted heat, delivered through a small insertion and guided into the prostate by magnetic resonance imaging, to burn away cancerous cells in the prostate. Read the article.

Focal Therapy Offers Middle Ground for Some Prostate Cancer Patients Read More »

Prostate cancer now detectable using imaging-guided biopsy

Diagnosis / By / / 1 minute of reading

Groundbreaking research by a team of UCLA physicians and engineers demonstrates that prostate cancer — long identifiable only through painful, hit-or-miss biopsies — can be diagnosed far more easily and accurately using a new image-guided, targeted biopsy procedure. Read the article, which includes a video.

Prostate cancer now detectable using imaging-guided biopsy Read More »

Scroll to Top